Elorza María Eugenia, Moscoso Nebel Silvana, Ripari Nadia Vanina
Bachelor of Economics. Doctoral Fellow at the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Teaching assistant of Statistics, Department of Mathematics, Universidad Nacional del Sur, Argentina.
Bachelor of Economics. PhD in Economics. Assistant researcher at the Consejo Nacional de Investigaciones Científicas y Técnicas(CONICET). Associate Professor of Health Economy, Department of Economy, Universidad Nacional del Sur, Argentina.
Salud Colect. 2012 Jan-Apr;8(1):35-45. doi: 10.18294/sc.2012.126.
In Argentina, the provision of drugs for patients suffering from type 2 diabetes mellitus who lack health insurance is carried out through public programs. In the Province of Buenos Aires, the national program Remediar and the provincial program PRODIABA (from the Spanish Programa de Prevención, Diagnóstico y Tratamiento del Paciente Diabético) coexist. This study estimates the percentage of adults in the municipality of Bahia Blanca (Province of Buenos Aires) who suffer from type 2 diabetes mellitus and lack health insurance, thus satisfying their need for oral antidiabetic treatments within the public sector. It is a quantitative study that assesses the need and demand for public provision. The results indicate that: 1) the greatest percentage of demand is satisfied at the primary health care level; 2) the province of Buenos Aires funds the largest share of the pills, followed by the municipal and the national levels; 3) the local government intervenes to satisfy the demand and 4) the total public provision covers approximately 25% of the overall need in relation to the average consumption. This shows that despite the presence of these public programs, the provision is insufficient and thus requires the intervention of the local government even though economic theory does not recommend the decentralization of drug purchases.
